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The ubiquitous presence and chronic effect of pharmaceuticals is one of the 
emerging issues in environmental field. As a result of incomplete removal by sewage 
treatment plants, pharmaceuticals are released into the environment and drinking water 
sources. On the other hand, conventional drinking water treatment processes such as 
coagulation, filtration and sedimentation are reported to be ineffective at removing 
pharmaceuticals. Therefore, the potential presence of pharmaceuticals in finished 
drinking water poses a threat on public health. Antibiotics, as an important group of 
pharmaceuticals, are given special concerns because the potential development of 
bacteria-resistance.  
 viii 
Ozonation and advanced oxidation processes are shown to be quite effective at 
removing pharmaceuticals. The oxidation of pharmaceuticals is caused by ozone itself 
and hydroxyl radicals that are generated from ozone decomposition. Whether ozone or 
hydroxyl radicals are the primary oxidant depends on the specific pharmaceutical of 
interest and the background water matrix.  
In this research, erythromycin, a macrolide antibiotic, was chosen as the target 
compound because of its high detection frequency in the environment and its regulation 
status. The objective of this research was to investigate the removal performance of 
erythromycin by ozonation from the standpoint of kinetics. The effects of pH, carbonate 
and phosphate buffers, and initial ozone dose on ozonation of erythromycin were also 
studied. The second-order rate constant for the reaction between deprotonated 






 while protonated 
erythromycin did not react with ozone. Ozone was determined to be the primary oxidant 
for erythromycin removal by ozonation. pH was found to have great positive impact on 
the degradation of erythromycin by ozonation due to the deprotonation of erythromycin 
at high pH. Carbonate and phosphate buffers were found to have negligible effects on the 
degradation of erythromycin by ozonation. Initial ozone dose showed a positive impact 
on the total erythromycin removal rate by ozonation.  
 ix 
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Chapter 1 Introduction  
1.1 RESEARCH OBJECTIVE 
The ubiquitous presence and the potential chronic effects on human health make 
the occurrence and fate of pharmaceuticals an emerging issue in the environmental field. 
Pathways for pharmaceuticals entering the environment mainly include the discharge of 
wastewater from sewage plants and runoff associated with veterinary use. The occurrence 
of pharmaceuticals in surface water and groundwater raises concerns about drinking 
water safety. The use of contaminated drinking water sources leads to the possibility of 
the presence of pharmaceuticals in finished drinking water.  
Antibiotics, an important group of pharmaceuticals, are always of great concern 
because of their indispensable use and the possibility of developing bacterial resistance. 
Antibiotics may be present either as the original “parent” compound if complete removal 
is not achieved during treatment or as transformation intermediates with unknown 
toxicity that are produced during chemical processes such as oxidation. Erythromycin 
belongs to the macrolide subclass of antibiotics; it is widely used for control of bacteria 
in humans as well as in food-producing animals. Erythromycin is chosen as the target 
compound in this research for three primary reasons: a high frequency of detection, 
concerns regarding its persistence in the environment and potential for upcoming 
drinking water regulations.  
Conventional drinking water treatment processes such as coagulation, 
sedimentation and filtration are found to be ineffective at removing pharmaceuticals. 
Ozonation and advanced oxidation processes have shown promise as a treatment 
alternative for a number of pharmaceuticals. Moreover, existing drinking water treatment 
plants could easily be upgraded or retrofitted for these technologies. However, the cost 
associated with advanced oxidation processes in aqueous media is likely to be high, 
especially when treatment cost per unit mass is considered because the initial 
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concentration of most pharmaceuticals is expected to be extremely low in drinking water 
sources.  
The oxidation of pharmaceuticals by ozone may occur by ozone itself and/or by 
hydroxyl radicals that are generated during ozone decomposition. Ozone is a relatively 
selective oxidant which only reacts with certain functional groups; on the other hand, 
hydroxyl radicals are rather non-selective oxidant and may attack at any number of sites 
on a given pharmaceutical. The non-specificity of hydroxyl radicals is reflected by the 
similarity among rate constants for the degradation of several target compounds by 
hydroxyl radical (Broseus et al., 2009). Therefore, advanced oxidation processes have 
emerged in an effort to generate as much hydroxyl radical as possible by combining the 
use of chemical agents, irradiation and catalysts. However, whether ozone or hydroxyl 
radicals are the main contributor to the degradation of a particular pharmaceutical 
depends on the particular target compound and the background water chemistry. 
Common background water parameters, such as pH, alkalinity and natural organic matter 
affect the rate of ozone decomposition, i.e., hydroxyl radical exposure; therefore, they 
have an indirect impact on the removal of pharmaceuticals by ozonation. Initial ozone 
dose is also a key operating parameter that should be taken into consideration. The effect 
of pH is especially complex; on one hand, it affects the speciation of some target 
compounds and thus their reactivity with ozone; on the other hand, it determines the 
speciation of carbonate buffer and natural organic matter.     
The degradation of two compounds that are similar to erythromycin, namely 
roxithromycin and clarithromycin, by ozonation has been studied and the second order 
rate constants between these compounds and ozone have been reported (Lange et al., 
2006; Huber et al., 2003). However, no data yet is available for the degradation of 
erythromycin degradation by ozonation. Furthermore, the effect of natural water 
constituents on the ozonation of erythromycin has not been investigated.  
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1.2 OBJECTIVES AND APPROACH 
This research was designed to evaluate the kinetics of erythromycin degradation 
by ozonation. The objectives of this research are outlined below: 
 Determine the rate constant for the reaction between erythromycin and 
ozone.  
 Determine the rate constant for the reaction between erythromycin and 
hydroxyl radicals 
 Identify the primary oxidant responsible for erythromycin degradation 
during ozonation 
 Investigate the effect of pH, carbonate and phosphate buffers, and initial 
ozone dose on erythromycin degradation by ozonation 
1.3 RESEARCH APPROACH 
To achieve the objectives of this research, batch experiments were conducted to 
examine concentrations of erythromycin as a function of time under various background 
conditions of pH, carbonate and phosphate buffer concentrations, and initial ozone dose.  
1.4 THESIS STRUCTURE 
This thesis is divided into five chapters that provide an introduction, background 
knowledge, methodologies, results and conclusions. Chapter 1 serves as a brief 
introduction describing the motivation and objectives of this research. Chapter 2 presents 
a literature review including the occurrence of pharmaceuticals in the environment, 
treatment processes for pharmaceutical removal from water with emphasis on ozonation 
and advanced oxidation processes, and previous research results that have applied 
ozonation to macrolide antibiotics. Materials and methods employed in this research are 
described in Chapter 3. Chapter 4 presents the interpretation of the experimental data and 
discussion based on the results. The last chapter provides the conclusions and 
recommendations of future work.     
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Chapter 2 Literature Review 
2.1 INTRODUCTION 
The ultimate objective of this research is to delineate the effect of natural water 
parameters on the kinetics of degradation of erythromycin by ozonation. The 
achievement of this goal necessitates the understanding of the chemistry of erythromycin, 
the ozonation process and the impact of several natural water parameters on the 
ozonation processes. This literature review aims to provide basic background knowledge 
related to this research. First, the occurrence of pharmaceuticals in the environment and 
their potential effects are presented. Antibiotics, especially erythromycin, are described in 
greater details since erythromycin is the target compound of this research. A review of 
treatment processes to remove pharmaceuticals both in drinking water treatment and 
wastewater treatment follows the review of the impacts of pharmaceuticals. Ozone and 
advanced oxidation processes are described in a separate section dedicated to examining 
the effects of natural water characteristics on the ozonation process, which is closely 
related to the goal of this research. Finally, previous research results regarding ozonation 
of macrolide antibiotics are presented. 
2.2. PHARMACEUTICALS IN THE ENVIRONMENT AND ERYTHROMYCIN 
2.2.1 Pharmaceuticals in the environment 
Interest in and concerns about the ubiquitous presence of pharmaceuticals in the 
environment have grown dramatically in the past few years, especially due to the 
application of advanced measurement technologies (Fatta et al., 2007). Pharmaceuticals 
are a class of chemical substances that are designed to have a physiological effect on 
humans and animals (Klavarioti et al., 2009). Compared with the persistent organic 
pollutants in soil or sediment, which can be present with concentrations in the range of 
mg/L, the concentrations of pharmaceuticals in the environment are usually found at 
levels in the range of μg/L (Kim & Aga 2007); as a result, their presence as 
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environmental pollutants has been generally overlooked in the past. Occurrences of 
pharmaceuticals in the water environment have been reported worldwide, including the 
United States (Kolpin et al., 2002), Germany (Ternes 1998), Italy (Lalumera et al., 2004), 
Spain (Rodríguez et al., 2003), and Taiwan (Lin et al., 2008). Pharmaceutical compounds 
detected include antibiotics, anticonvulsants, painkillers, cytostatic drugs, hormones, lipid 
regulators, beta-blockers, antihistamines, and X-ray contrast media (Ikehata et al., 2006). 
The presence of pharmaceuticals have been reported in groundwater (Eckel et al., 1993; 
Holm et al., 1995) , surface water (Watts et al., 1983; Aherne et al., 1985), drinking 
water (Halling-Sørensen et al., 1998; Ternes et al., 2002a; Doll & Frimmel 2003), 
sediment (Coyne et al., 1994; Kerry et al., 1995), ocean (Lee & Arnold 1983) and soil 
(Warman & Thomas 1981).  
Several pathways are available for pharmaceuticals to enter the environment. The 
primary pathway is through discharges of treated wastewater from sewage plants. After 
being ingested and metabolized, pharmaceuticals are excreted via urine and feces and 
then sent to wastewater treatment plants (WWTP). However, WWTPs are not designed to 
remove polar and large micropollutants like pharmaceuticals. Depending on the nature of 
specific pharmaceuticals and the processes employed by different WWTPs, the removal 
efficiency of pharmaceuticals encompasses the entire range from 0% to 100% 
(Radjenovic et al., 2007; Drewes 2007). Due to the low concentrations of 
pharmaceuticals in wastewater, enzyme affinities might be limited, meaning that the 
degradation of pharmaceuticals is more likely to occur in receiving waters or sediments 
than in WWTPs (Daughton & Ternes 1999). Pharmaceuticals can also be introduced to 
landfills in direct (via domestic and industrial routes) and indirect (via sewage sludge) 
ways. Although few pharmaceuticals have been detected in domestic drinking water, the 
presence of pharmaceuticals is possible when polluted groundwater is employed as a 
water source and treatment technologies do not remove the pharmaceuticals from 
drinking water treatment plants.  
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The focus of research regarding pharmaceuticals has shifted from early analysis 
and detection of the compounds in various water sources to dose-response studies of the 
pharmaceuticals in the lab and in field trials (Kümmerer 2009). Although the 
concentration of pharmaceuticals detected in the aquatic environment is quite low (in the 
range of ng/L to μg/L), recent research suggests that even this low concentration of 
pharmaceuticals in the environment could yield adverse ecological and human health 
effects. For example, the synthetic hormone 17α-ethynil estradiol at ng/L concentrations 
typically found in sewage effluents has the potential to induce endocrine disruption 
(Desbrow et al., 1998; Routledge et al., 1998). Moreover, pharmaceuticals are not 
typically present as individual compounds, but rather as multi-component mixtures in the 
environment, which raises the concern for synergistic and variable effects compared to 
responses observed for isolated exposure to the pure substance (Kümmerer 2009). The 
potential interactions among individual pharmaceuticals present at trace concentrations 
are difficult to evaluate.  
Another concern regarding the effect of pharmaceuticals is the potential risk of 
long-term exposure on aquatic and terrestrial organisms as a result of continuous 
pharmaceutical input and environmental persistence. Resistance to biodegradation is a 
key property of pharmaceuticals. Several commonly used pharmaceuticals such as 
erythromycin, cyclophosphamide, naproxen and sulphamethoxazole could persist for 
more than one year (Zuccato et al., 2000). The potential for persistence combined with 
proven ecological impacts has led to regulation of a number of pesticides such as DDT; 
however, it is unlikely that limitations will be placed on the use of pharmaceuticals due to 
their known health benefits to humans as well as their economic importance (Jones et al., 
2005). The increasing use and environmental persistence of pharmaceuticals implies that 
there is significant potential for long-term exposure of pharmaceuticals to organisms in 
the environment.  
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Whether the concern for the presence of pharmaceuticals in drinking water is 
warranted is still under debate.  Indeed, there are several studies suggesting that the 
effects of pharmaceuticals on human health are minimal. Schwab et al. (2005) evaluated 
the potential effect on human health of 26 active pharmaceutical ingredients and/or their 
metabolites in US surface waters. They reached the conclusion that the trace 
concentrations of pharmaceuticals in surface water and drinking water had no appreciable 
risk to human health. In contrast, a concern because of the possible development of 
antibiotic-resistant bacteria (Boreen et al., 2004; Qiang et al., 2004; Andreozzi et al., 
2006). 
2.2.2 Antibiotics  
Antibiotics, an important group of pharmaceuticals, are widely used for treating 
bacterial infection in both human and veterinary medicine (Hirsch et al., 1999). The 
presence of antibiotics has been detected in surface water in many countries such as the 
United States, Canada, Germany and other European countries. Examples of common 
antibiotics detected include macrolide antibiotics (clarithromycin, dehydro-
erythromycin), sulfonamides, fluoroquinolones and trimethoprim (Hirsch et al., 1999; 
Ternes 2001; Kolpin et al., 2002; Metcalfe et al., 2003; Bruchet et al., 2005).  
Antibiotics enter the environment mainly through the discharge of wastewater 
treatment plants or land application of sewage sludge (Kim & Aga 2007). Unmetabolized 
antibiotics can leave an organism via urine or feces. The incomplete elimination of 
antibiotics by wastewater treatment plants would then result in the presence of antibiotic 
substances in the receiving surface waters (Ternes 1998). Runoff deriving from the 
dispersion of manure on fields as fertilizer is an alternative pathway into the aquatic 
environment (Hirsch et al., 1999).  
Depending on the specific antibiotic property and different wastewater treatment 
processes employed, the removal efficiency of different antibiotics in wastewater 
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treatment plants varies. Kasprzyk-Hordern et al. (2009) launched a 5-month monitoring 
program in the UK to determine the fate of 55 pharmaceuticals in two different 
wastewater treatment plants using different treatment technologies. They found that the 
removal efficiencies of erythromycin-H2O and sulfamethoxazole were 50% and 70% in 
one wastewater treatment plant, respectively, while no removal was observed in the other 
treatment plant.  
The removal mechanisms of antibiotics in wastewater treatment plants include 
biodegradation, adsorption to activated sludge, volatilization due to aeration and 
photodegradation, with the first two identified as the primary mechanisms (Kim & Aga 
2007). The octanol-water partitioning coefficient, Kow, is a parameter that is often used to 
estimate the potential for adsorption of hydrophobic contaminants to sludge or sediments. 
However, in contrast to highly lipophilic contaminants such as polychlorinated biphenyls, 
the molecular structures of antibiotics have multiple functional groups that exhibit 
varying properties such as acidity and polarity. For example, a given antibiotic may 
contain both acidic and basic groups within the same molecule. Therefore, the sorption of 
antibiotics depends not only on the log Kow value, but is also affected by pH, redox 
potential, stereo chemical structure and chemical nature of both the sorbent and the 
sorbed molecule (Kümmerer 2009).  
Although the concentrations of antibiotics reported in the environment are 
generally in the μg/L or even ng/L range, two major concerns are associated with low-
level antibiotic exposure. First, ecosystems and human health may be adversely affected 
by chronic exposure; second, such exposure can result in the development of antibiotic-
resistant bacteria (Boreen et al., 2004; Qiang et al., 2004; Andreozzi et al., 2006).  
Antibiotics are usually divided into four sub-classes, including β-lactam, 
macrolide, quinolone, and tetracycline, as well as several other types of antibiotics that do 
not belong to these subclasses (Ikehata et al., 2006). Azithromycin, clarithromycin, 
erythromycin and roxithromycin belong to macrolide antibiotics, which are characterized 
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by their ability to inhibit bacterial protein synthesis (Beers & Berkow 1999) and the 
possession of tertiary-amine groups, as shown in Figure 2.1. For this research, 
erythromycin was chosen as the target compound because of its high detection frequency 
in the environment, which will be described in details in Section 2.2.3.  
 
Figure 2.1: Molecular structure of common macrolide antibiotics (Ikehata et al., 2006)  
2.2.3 Erythromycin 
Erythromycin is a therapeutically useful, wide-range macrolide antibiotic 
produced by the actinomycete species, Streptomyces erythreous (McGuire et al., 1952); it 
is used in humans as well as in food-producing animals to control bacterial diseases and 
promote animal growth (Pothuluri et al., 1998). It is interesting to note that consumption 
of macrolide antibiotics varies dramatically in different countries. For example, the use of 
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erythromycin was approximately 1200 mg per person per year in the UK while it was 
only 24 mg per person per year in Switzerland (McArdell et al., 2003). The chemical 
structure of erythromycin is shown in Figure 2.1. Erythromycin contains a 14-membered 
lactone ring with ten asymmetric centers and two sugars (L-cladinose and D-desosamine). 
As the result of the tertiary amine of desosamine, erythromycin has a pKa of 8.8 (Kanfer 
et al., 1998).  
The presence of erythromycin in the environment has been reported by many 
researchers. Kolpin et al. (2002) analyzed 85 organic wastewater contaminants in 139 US 
stream sites that were considered susceptible to contamination. Among 21 detected 
veterinary and human antibiotics, dehydro-erythromycin (erythromycin-H2O) was most 
frequently detected with a detection frequency of 21.5%; the maximum and median 
concentrations of dehydro-erythromycin were 1.7 μg/L and 0.1 μg/L, respectively. Lin et 
al. (2008) investigated eleven antibiotics in three rivers in Taiwan and found consistent 
presence of erythromycin-H2O and a maximum concentration of 76 μg/L. Høverstad et 
al. (1986) determined several antibiotics in human feces during 6 days of regular 
application and found erythromycin concentrations ranging from 200 to 300 mg/kg. 
In September 2009, EPA published a final list of contaminants which might 
require regulation under the Safe Drinking Water Act (SDWA). In this final Contaminant 
Candidate List 31 (CCL3), erythromycin is the only antibiotic that was added from the 
draft to the final CCL3 along with nine hormones under the category of pharmaceuticals, 
based on new health effects and occurrence data in ambient water. The high frequency of 
detection, the environmental persistence and the regulatory status are the main reasons 
that erythromycin was chosen as the target compound in this research.  
As confirmed by experiments using the published analytical procedure, 
erythromycin was not detected in its original form but as a self-degradation product with 
                                                 
1 http://water.epa.gov/scitech/drinkingwater/dws/ccl/ccl3.cfm#chemical 
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an apparent loss of one molecule of water: erythromycin-H2O (Hirsch et al., 1999). Kim 
et al. (2004) conducted a kinetic study on the self-degradation of erythromycin A, the 
major component of erythromycin base, in aqueous solution. The degradation of 
erythromycin A can be described by a first-order reaction with respect to the 









 (Equation 2.1) 
where [EA] is the concentration of erythromycin A; kobs, (min
-1
) is the observed 
degradation rate constant.  
They proposed an empirical model ( 
Figure 2.2) to interpret the observed rate constant kobs as a function of pH at 25°C: 
 )387.0(8)870.0( 10)1070.2(102.17 pHpHobsk
   (Equation 2.2) 
According to the model, the slowest degradation of erythromycin occurred around 
pH 7.3; increasing or decreasing the pH from 7.3 resulted in more rapid self-degradation 
of erythromycin. In this research, the pH of the samples was lowered to approximately 
2.5 prior to analysis as a consequence of adding indigo reagent for ozone measurement. 
At pH 3, the observed self-degradation rate constant, kobs, was 0.042 min
-1
; this rate 
constant would result in a half-life of approximately 16 min. In other words, over 90 
percent of the erythromycin initially present in a sample would degrade into 
erythromycin-H2O within one hour. Therefore, erythromycin-H2O was measured in this 
research rather than erythromycin.   
 12 
 
Figure 2.2: Prediction of erythromycin A degradation in terms of pH of aqueous solution 
(Kim et al., 2004). Measured data points were obtained from Kim et al. (2004, ●), Atkins 
et al. (1986, ○), Cachet et al. (1989, △), and Volmer & Hui (1998, □). 
2.3 TREATMENT OF PHARMACEUTICALS 
2.3.1 Drinking water treatment 
The presence of pharmaceuticals in drinking water has rarely been reported, in 
part due to the limited number of studies and lack of regulatory reporting requirements.  
However, Daughton (2010) presented a comprehensive review of the literature reporting 
pharmaceuticals and related products in source waters and finished drinking water. 
Several pharmaceuticals, including erythromycin (the subject of this study) have been 
reported in the finished drinking water of more than one plant. The concentrations in 
finished drinking water, however, have rarely been above 1 ng/L.  
Conventional treatment including coagulation, flocculation, sedimentation and 
filtration are reported to achieve minimal removal (Westerhoff et al., 2005). Boyd et al. 
(2003) showed that oxidation (e.g., chlorination and ozonation) and sorption (dual media) 
processes might be effective at removing naproxen. Ternes et al. (2002) investigated the 
elimination of selected pharmaceuticals during drinking water treatment at laboratory and 
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pilot scale as well as in actual treatment plants. The results showed that slow sand 
filtration and flocculation by iron (III) chloride were inefficient at removing 
pharmaceuticals while activated carbon filtration and ozonation were very effective 
removal processes. Huerta-Fontela et al. (2010) reached a similar conclusion. They 
studied the removal of 55 pharmaceuticals, hormones and metabolites through a drinking 
water treatment plant and they reported that coagulation, flocculation and sand filtration 
were ineffective while chlorination and ozonation processes accounted for higher 
efficiencies. However, even if processes such as ozonation, chlorination or 
photodegradation are efficient at removing pharmaceuticals, degradation by-products 
may be potentially toxic (Mompelat et al., 2009).  
2.3.2 Wastewater treatment 
The main mechanisms of pharmaceutical removal in wastewater treatment 
process are transformation in secondary (biological) treatment and sorption. Conventional 
activated sludge treatment was reported to degrade pharmaceuticals to varying extents 
that ranged from very poor to complete degradation (Gobel et al., 2007). Nakada et al. 
(2007) showed that the combination of conventional activated sludge treatment, sand 
filtration and ozonation was effective at removing pharmaceuticals in a sewage treatment 
plant, although the individual removal efficiency of the first two steps were moderate or 
poor.  
However, even when complete removal of pharmaceuticals from an activated 
sludge process has been observed, partial or complete degradation may not have 
occurred; sorption from wastewater onto activated sludge is possible without 
transformation or complete mineralization (Kasprzyk-Hordern et al., 2009). It is also 
worth mentioning that antibiotics have the potential to inhibit the growth of 
microorganisms which is another important area of research that needs to be addressed in 
the future  
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2.4 OZONATION AND ADVANCED OXIDATION PROCESS 
Various studies have shown that ozonation is a promising technology for the 
oxidation of pharmaceuticals in drinking water (Huber et al., 2003; Ternes et al., 2002) 
and wastewater (Ternes et al., 2003; Huber et al., 2005). Kim and Tanaka (2010) 
investigated the removal of 40 pharmaceuticals by ozone-based processes in wastewater 
and found that an ozone dose of more than 6 mg/L plus a contact time of more than 10 
minutes yielded removals of greater than 90% for all pharmaceuticals investigated. For 
drinking water treatment, ozone has traditionally been employed for odor and taste 
control and disinfection. Jasim et al. (2006) evaluated the occurrence of pharmaceuticals 
and endocrine disruption chemicals in the Detroit River water, which is the source of 
drinking water for approximately 4.5 million residents. They concluded that ozonation 
showed great promise and should be considered as the focus of treatment studies for the 
removal of pharmaceuticals in the Great Lakes Region since other treatment processes 
showed minimal removal of pharmaceuticals. 
2.4.1 Ozone properties 
Ozone is a light blue gas with pungent odor which can be detected at 
concentrations as low as 0.01 ppm. It is 1.5 times as dense as oxygen and 12.5 times as 
soluble in water. Due to its unique structure, ozone can behave as a dipole, an 
electrophilic or nucleophilic agent (Kasprzyk-Hordern et al., 2003). 
Ozone is currently used as a strong oxidant/disinfectant in water treatment 
throughout Europe and in numerous drinking water treatment plants in the United States. 
The application of ozone has been used for disinfection, taste and odor control, oxidation 
of iron, manganese and sulfides, and micropollutant removal (Crittenden et al., 2005).  
2.4.2 Ozone decomposition 
One of the reasons that ozone has not been as popular as other disinfectants in the United 
States is due to its rapid decay. The decay of ozone in aqueous solution has been studied 
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for decades. According to kinetic studies, the decomposition of ozone is usually 
described by a two stage process. The first stage is characterized by a rapid depletion of 
ozone during the initial phase (t < ~20s) of ozone introduction, which is considered to be 
caused by constituents that are readily oxidized by ozone; this stage is also defined as 
instantaneous ozone demand (Buffle et al. 2006a).The second stage of ozone decay is 
described by a first-order radical chain process (see  
Figure 2.3); once hydroxyl radicals are produced, they will react with ozone to 
generate more hydroxyl radicals in a chain reaction process. According to a model, 
proposed by Hoigne, Staehelin and Bader (HSP), the radical chain reaction process can 
be initiated, promoted and inhibited by different compounds in natural water. The 
initiator of the free-chain reaction can be any compound  that can induce the formation 
of superoxide (O2
-
), for example, hydroxide ion (OH
-
), H2O2, UV at 253.7nm (Langlais et 
al.,1991). Promoters and inhibitors are considered hydroxyl radical scavengers. The 
difference between the two groups of compounds is that promoters can produce O2
-
 
superoxide anion or other species that is capable of accelerating the chain reaction; on the 
other hand, inhibitors consume hydroxyl radicals without generating the superoxide anion 
O2
-
. Common promoters include humic acid, formic acid, primary alcohols; common 
inhibitors are bicarbonate and carbonate ions, alkyl groups, tertiary alcohols. Regarding 
phosphate, there are different opinions about whether it is regarded as an inhibitor or just 
as an inert compound (Mizuno et al., 2007; Morozov & Ershov 2010). Natural organic 
matter can serve as an inhibitor or promoter depending on the specific functional groups.   
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Figure 2.3: Global cycle of ozone decomposition in water (adopted from Masschelein, 
1992) 
2.4.3 Advanced oxidation process 
The oxidation of pharmaceuticals can be caused by O3 directly or indirectly by 
hydroxyl radicals (
°
OH), a product of ozone decomposition (Hoigne & Bader 1976). 
Sufficient hydroxyl radicals would be produced only when ozone doses exceed the 
instantaneous ozone demand (Wert et al., 2009). Compared with hydroxyl radicals, ozone 
is a relatively selective oxidant which only attacks certain functional groups of the target 
compound; on the other hand, the hydroxyl radical is a nonselective oxidant and can react 
with a large number of functional moieties.   
Since the hydroxyl radical is a much less selective oxidant compared with ozone, 
an advanced oxidation process (AOP) is defined as an oxidation process that generates 
sufficient hydroxyl radicals to affect water treatment (Kasprzyk-Hordern et al., 2003). 
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AOPs utilize a combination of chemical agents (e.g., ozone, hydrogen peroxide), 
irradiation (e.g., UV, ultrasound) and catalysts (e.g., transition metals, metal oxides) to 
generate as much hydroxyl radicals as possible. Examples of AOPs include O3/H2O2, 
O3/UV, O3/H2O2/UV, Fe
2+
/H2O2. The diversity of technologies involved and the potential 
areas of application have resulted in immense research and development regarding AOPs 
(Klavarioti et al., 2009).  
In addition to the production of higher concentrations of hydroxyl radicals during 
advanced oxidation, another advantage of an O3/H2O2 AOP over the ozone process is that 
the former one would result in less residual ozone concentration and therefore reduce the 
formation of bromate (Kim & Tanaka 2010).   
The cost regarding treatment of pharmaceuticals by AOPs in aqueous media is 
likely to be relatively high because high conversion is required since even at minute 
concentrations these compounds retain their adverse effect; additionally, initial 
concentration are usually very low resulting excessive treatment cost per unit mass 
(Klavarioti et al., 2009).  
2.4.4 Kinetics of oxidation with ozone 
Reactions between ozone and pharmaceuticals, P, are typically described by an 
overall second-order reaction, i.e., first-order with respect to each oxidant (ozone and 
hydroxyl radicals) and first order with respect to the contaminant as shown by Equation 
2.3 and Equation 2.4 (Von Gunten 2003): 
 ]][[]][[ 33 OHPkOPkr OHOP

  (Equation 2.3) 





 , so upon integration, we find: 










  (Equation 2.4) 
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with )(][ 3 tfO   and )(][ tfOH 
 . [P], [O3] and [°OH] are concentrations of 





k  are physical-chemical constants and oxidant exposures (  dtO ][ 3 and 
 dtOH][

) are dependent on a number of operating and environmental conditions such 
as pH, alkalinity, initial ozone dose and scavenging capacity of water matrix (Buffle et 
al., 2006a). Usually, 10 mM of tert-butanol (t-butanol) was added in order to determine 
the 
3O
k value (Marron, 2010). The calculation of these parameters is shown in Chapter 4.  





only differ by one order of magnitude due to the low selectivity of 
°
OH radicals. The 






 (Broseus et al., 2009). In contrast, ozone 
rate constants 
3O
k differ substantially depending on the compound. 
The relative importance of 
°
OH oxidation versus O3 oxidation can be quantified 
using the molar ratio of hydroxyl exposure to ozone exposure, Rct (Elovitz & von Gunten 
1999): 
   dtOdtOHRct ][/][ 3

 (Equation 2.5) 
Employing the Rct concept, Equation 2.4 can be rewritten as Equation 2.6: 









  (Equation 2.6) 
Rct was observed to remain constant during ozonation processes in natural water 
(Elovitz & von Gunten 1999), which allows for simplification of the mathematical 
solution. However, in wastewater ozonation, Rct was shown to vary; as a result the Rct 
concept is not recommended for modeling compound degradation in wastewaters (Buffle 
et al., 2006b). Another limitation of the Rct concept occurs in systems in which 99% 
removal is achieved prior to measuring ozone exposure (Wert et al., 2009).  
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2.4.5 Impact of natural water characters on ozonation process 
Natural water characteristics affect the performance of ozonation process mainly 
through their impact on ozone decomposition, i.e., indirect reaction of ozone. The 
parameters considered here are temperature, pH, carbonate and phosphate buffers, natural 
organic matter and initial ozone dose.  
2.4.5.1 Temperature 
Temperature is negatively correlated with ozone solubility while it is positively 
correlated with ozone decomposition rate. Higher temperatures reduce the solubility of 
ozone, and therefore less ozone is available for direct reaction. On the other hand, the 
decomposition of ozone based on a second-order reaction model was calculated to be 2.2 
times faster for every 5°C increase in temperature within the range of 15 ~ 30°C (Mizuno 
et al., 2007), suggesting that more hydroxyl radicals can be generated at higher 
temperature. Furthermore, the reaction kinetics between pharmaceuticals and ozone also 
increase with increasing temperature.  
2.4.5.2 pH 
pH has a more complex impact on the removal of pharmaceuticals by ozone 
processes. First of all, ozone decomposition is directly affected by pH through the 
initiation reaction between ozone and hydroxide anions (OH
-
). Therefore, a higher pH 
leads to faster ozone decomposition and less ozone stability, while lowering the pH 
stabilizes aqueous ozone. Elovitz et al. (2000) showed that the second-order ozone 
decomposition rate increased by a factor of 3.55 per unit pH increase. On the other hand, 
pH also affects the speciation of deprotonated and protonated moieties. As shown by 
Dodd et al. (2006), the apparent second-order rate constant of macrolides was strongly 
dependent on pH because ozone was more reactive with deprotonated tertiary amines. 
Moreover, pH also affects the properties of other common natural water parameters, such 
as speciation of the carbonate buffer and natural organic matter, which indirectly affects 
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ozone decomposition. Models have been developed to address the impacts of these 
parameters on ozone decomposition and these models should be modified to address the 
impacts on degradation of pharmaceuticals by ozonation.  
2.4.5.3 Carbonate buffer 
As mentioned above, chemical speciation of the carbonate buffer is determined by 
pH. However, for the pH range prevalent in most natural waters, the dominant species is 
bicarbonate. Bicarbonate and carbonate are known to be ozone decomposition inhibitors 
by scavenging hydroxyl radicals without generating superoxide (O2
-
) or other species that 
can accelerate the decomposition of ozone (Staehelin & Hoigne 1985). The reactions 




 are shown by Equation 2.7 and Equation 
2.8 (Buxton et al., 1988).  
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 concentration increases, the ozone decomposition 
rate decreases resulting in higher ozone exposure and lower hydroxyl radical exposure. It 





 concentration (Elovitz et al., 2000). However, the impact of 
carbonate buffer on the removal of a specific pharmaceutical by ozonation depends on 
whether ozone itself or hydroxyl radicals govern the oxidation. If the oxidation is primary 





concentration would lead to a higher oxidation efficiency; on the other hand, if direct 





concentration would have less of a positive effect or, perhaps, even negative effect on the 
removal efficiency.  
                                                 
2 HCO3
-/CO3
2- is not the ratio of HCO3
- to CO3




2.4.5.4 Phosphate buffer 
Phosphate is used extensively as a buffer in studies of ozone self-decomposition 
in “pure” water in which it is assumed that it does not react with ozone (Morozov & 
Ershov 2010). However, there are some reports suggesting that phosphate species can 
affect ozone decomposition. Sotelo et al. (1987) showed that the rate constant for ozone 
decomposition decreased by a factor of 30 when the concentration of phosphate increased 
from 0.1 to 1.0 M. Morozov & Ershov (2010) also found that, at all pH values, the rate 
constant of ozone decomposition decreased as phosphate concentration increased. On the 
other hand, according to Mizuno et al. (2007), phosphate buffer did not influence the 
second-order rate constant for ozone decomposition. As a whole, the argument that 
phosphate does affect ozone decomposition seems to be more persuasive.  
2.4.5.5 Natural organic matter 
Natural organic matter (NOM) is ubiquitous in the environment and contains a 
heterogeneous mixture of organic compounds that makes the quantification and 
identification of its structural characteristics very difficult. It is measured most commonly 
by using total organic carbon (TOC) as a surrogate.  
NOM can directly react with ozone (Equation 2.9 and Equation 2.10) or affect 
ozone stability by scavenging 
°
OH radicals (Equation 2.11 and Equation 2.12), either as a 
promoter with the formation of O2
-
 or as an inhibitor. The effect of NOM on ozone 
stability not only depends on the concentration of NOM, but also its origin and 
composition (Buffle et al., 2006a). Elovitz et al. (2000) found a three-fold difference of 
ozone decomposition rate in six waters with similar DOC concentration and alkalinity. Pi 
et al. (2005) found that aromatic compounds present at micromolar concentrations, could 
accelerate ozone decomposition considerably. Reactions of NOM with ozone have been 
described by the following equations (Westerhoff et al., 1999): 
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 productsNOMO 3  (Equation 2.9) 
 productsOHOHONOMO   )( 2223  (Equation 2.10) 
 productsONOMOH  2
  (Equation 2.11) 
 productsNOMOH   (Equation 2.12) 
For some pharmaceuticals, like carbamazepine and diclofenac, natural organic 
matter could absorb contaminants and therefore decrease their ability to be oxidized from 
advanced treatment processes (Jasim et al., 2006).  
2.4.5.6 Ozone dose 
Ozone dose is a key operating parameter when ozonation processes are applied. 
Buffle et al. (2006a) found that the rate of ozone decomposition decreased as ozone dose 
was increased. Various researchers have studied the impact of ozone dose on the removal 
performance of particular compounds. Ternes et al. (2003) applied a 5 mg/L ozone dose 
to sewage treatment plant effluent and five antibiotics that were studied including 
erythromycin (0.62±0.24 μg/L), clarithromycin (0.21±0.02 μg/L) and roxithromycin 
(0.54±0.04 μg/L), were no longer detected. However, it is difficult to determine the 
optimal dosage of ozone to achieve a given level of degradation in the complex 
background water matrices typically encountered and the range of pharmaceuticals that 
may be present in a system. And they concluded that long ozonation time coupled with 
large ozone dose did not have a significant impact on the level of degradation.  
2.5 OZONATION OF MACROLIDE ANTIBIOTICS 
Common macrolide antibiotics include azithromycin, clarithromycin, 
erythromycin and roxithromycin; lincomycin is a lincosamide antibiotic, which has a 
similar antibacterial spectrum with macrolides Ikehata et al. (2006). The primary ozone 
attack site of macrolides is the tertiary nitrogen (Huber et al., 2005). It is reported that 
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ozonation of azithromycin, erythromycin and clarithromycin could yield removal rates of 
90% to 99%with an ozone dose of more than 2 mg/L (Huber et al., 2005). 
Since the chemical nature of the reactive moieties is very similar for the 
macrolide antibiotics, the rate constants for the degradation of these moieties by O3 are 
expected to be very similar. Indeed, roxithromycin has been reported to have an apparent 






 at pH 7 (Dodd et al., 2006); clarithromycin is reported to 






 at pH 7 (Lange et al., 2006). The rate 
constant for reaction of azithromycin with ozone is expected to be higher because ozone 
can attack both the exocyclic tertiary amine and the heterocyclic tertiary amine. To date, 
there are no kinetic studies for erythromycin degradation by ozone reported in the 
literature but it is expected that the rate constant should be similar to roxithromycin and 
clarithromycin.  One of the objectives of this research is to determine the rate constant 
of the reaction between erythromycin and ozone because it is the only macrolide that is 
on the contaminant candidate list.  
Detailed kinetic studies and intermediate product identification were conducted 
on tertiary amines by Muñoz et al. (2001), Muñoz & von Sonntag (2000) indicating that 
the formation of N-oxide dominated (90%) the oxidation process. Lange et al. (2006) 
studied the degradation of clarithromycin by ozonation and they concluded that the 
oxidation product data for clarithromycin would be similar for all the other macrolide 
antibiotics. They identified the N-oxide as the major product for clarithromycin oxidation 
by ozone and suggested that this would also be the primary product for other macrolides. 
They also proposed that the formation of N-oxide inactivated the ribosomal antibiotic 
activity of clarithromycin  
Kim & Tanaka (2010) found that for erythromycin and clarithromycin, removal 
efficiency was only slightly increased when O3/H2O2 was applied instead of ozone only. 
This result indicates that for macrolides which already reacts very quickly with ozone 
itself, ozone is the main contributor to the degradation during O3/H2O2 process.  
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2.6 SUMMARY 
Ozonation of pharmaceuticals has been studied by many researchers and most of 
the results demonstrate that ozonation and/or advanced oxidation processes are very 
effective at removing pharmaceuticals in aqueous phase. The effects of natural water 
characteristics on ozonation of pharmaceuticals have also been investigated.  
Erythromycin, a very common antibiotic, is has been identified in source waters 
with high detection frequency and appears to be relatively persistent in the environment. 
The ozonation of erythromycin has not been investigated yet; although, ozonation 
kinetics and intermediate product identification has been reported for similar compounds. 
In this research, batch experiments were carried out to quantify the kinetics of ozonation 
of erythromycin and to evaluate the effects of natural water characteristics on ozonation 
of erythromycin.  
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Chapter 3 Materials and Methods 
3.1 INTRODUCTION 
This chapter describes the experimental methods and analytical techniques 
employed to achieve the goal of this research. The research design is presented first to 
provide an overview of the range of experimental conditions conducted. Then, 
experimental procedures for each set of experiment are described in detail. Finally, 
analytical methods for all the parameters involved are presented.  
3.2 RESEARCH DESIGN 
The high detection frequency and the anticipated regulation requirement led to the 
study of erythromycin removal by ozonation. This research was designed to determine 
the rate constant between erythromycin and ozone in a range of background waters to 
delineate the effects of pH, carbonate and phosphate buffers, and initial ozone dose on the 
removal rate of erythromycin by ozonation.  
 Many existing drinking water treatment plants use ozonation both as a 
pretreatment process for primary disinfection, reduction of color and odor compounds 
and as an indispensable disinfection process after filtration. These plants could simply 
improve trace organic contaminant removal performance by modifying operational 
conditions. pH and carbonate buffer were selected as the focus parameters because of 
their importance and ubiquity in drinking water treatment processes. Additionally, the 
effect of initial ozone dose was investigated since it is a direct operational parameter. The 
effect of phosphate buffer on the rate constant was also evaluated since it behaves as a 
hydroxyl radical scavenger just like carbonate, it is regarded as “inert” and is always 
neglected in studies of kinetics of ozone decomposition in “pure” water. Batch 
experiments were conducted to understand the effect of these parameters on the reaction 
kinetics of erythromycin degradation by ozonation. The matrix of the experiments is 
shown in Table 3.1. 
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Table 3.1: Matrix of experiments









1 5.35 10         
Determine the rate constant of 
erythromycin degradation by 
ozone only 
2 5.66 10         
3 6.00 10         
4 6.40 10         
5 6.81 10         
2 6 6.00 10   4     
Confirm that Erythromycin 
degradation by ozone only is 
not affected by the presence of 
carbonate 
3 
7 6.00   1 0 5 0.58 Understand the effect of 
carbonate buffer on ozone 
exposure and hydroxyl radical 
exposure 
8 6.00   1 0.5 5 0.68 
9 6.00   1 1 5 0.62 
4 
10 6.00   1 0 1 0.16 
Understand the effect of 
carbonate buffer on 
erythromycin degradation by 
ozonation  
11 6.00   1 1 1 0.16 
12 6.00   1 1 1 0.18 
13 6.00   1 2 1 0.16 
14 6.00   1 4 1 0.15 
5 
15 6.00   1 0 1 0.12 Understand the effect of buffer 
effect on erythromycin 
degradation by ozonation 
16 6.00   0.5 0 5 0.11 
17 6.00   0.5 0 10 0.10 
6 
18 6.00   0.5 0 5 0.27 Understand the effect of initial 
ozone dose on erythromycin 
degradation by ozonation 
19 6.00   1 0 5 0.17 
20 6.00   1 0 5 0.11 
 27 
3.3 EXPERIMENTAL PROCEDURES 
3.3.1 Ozone reactor setup 
The setup of the ozone reactor was described in detail by Marron (2010). Briefly, 
a concentrated aqueous ozone stock solution (typically between 50 mg/L and 65 mg/L 
after running ozone generator several hours) was prepared by bubbling ozone-containing 
O2 gas through a gas-washing bottle containing deionized water, which was cooled in ice 
to increase the solubility of ozone. A diagram of the ozone reactor is shown in Figure 3.1. 
 
 
Figure 3.1: Experiment setup (adopted from Marron, 2010) 
3.3.2 Experiment setup 
All the experiments were conducted in a 2 L, well-mixed amber glass reactor. A 
small hole was drilled near the top of the reactor for injecting aqueous ozone stock 
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solution. A bottle top dispenser (VWR LabMax) was utilized for taking samples during 
experiment; all wetted parts of the dispenser were made of Teflon. The range of the 
dispenser was from 0 mL to 25 mL; sample volume was typically 8 mL or 9 mL. During 
experiments, two additional extractions of samples were wasted before each sample was 
actually collected for analysis. Samples were also taken before the experiment to 
determine the initial erythromycin concentration. A picture of the experimental setup is 
shown in Figure 3.1.  
Reactions were initiated by injecting a certain amount of the aqueous ozone stock 
solution at time zero into the well-mixed reactor containing the reaction matrix of interest 
specified in Table 3.1. After each sample was taken with the dispenser, it was quenched 
immediately using an indigo solution and analyzed for O3 and other compounds as 
needed.  
3.3.3 Pre-experiment preparation 
All the glassware involved in the experiments was prepared as organic-free 
according to the following procedure: wash with Liqui-Nox soap, rinse six times with 
deionized water, soak at least for 30 minutes in a 10% nitric acid solution, rinse six times 
with deionized water and bake at 550°C for one hour (for amber glassware, bake at 
350°C overnight).  
3.3.4 pH experiment (Experiment Set No.1 and 2)  
The first set of experiments was designed to evaluate the effect of pH on the rate 
constant for degradation of erythromycin by ozone only. Experiments were conducted at 
five different pH values: 5.35, 5.66. 6.00, 6.41 and 6.81. pH was adjusted using 
concentrated HCl and NaOH; all other conditions were maintained at the same level as 
shown in Table 3.1. 10 mM t-butanol was added to isolate the reaction between ozone 
and erythromycin; the total carbonate concentration was negligible. The initial 
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erythromycin concentration was 1 mg/L, and the phosphate buffer concentration was 1 
mM.   
A second set of experiments was conducted at pH 6.00 with 4 mM total carbonate 
to confirm that the carbonate buffer did not affect the rates of degradation of 
erythromycin by ozone only.   
3.3.5 Carbonate experiment (Experiment Set No.3 and 4) 
Total carbonate concentration was the only variable for these two sets of 
experiments. The first set of experiments was conducted without erythromycin and was 
aimed to study the effect of carbonate concentration on ozone decomposition at pH 6.0. 
The total carbonate concentrations tested were 0 mM, 0.5 mM and 1 mM; 1 μM pCBA 
was added to track hydroxyl radical exposure. 
A second set of experiments were conducted with 1mg/L erythromycin at pH 6.0 
and 0 mM, 1 mM, 2 mM and 4 mM total carbonate concentration to study the effect of 
the carbonate buffer on ozonation of erythromycin as well as to obtain the rate constant 
between erythromycin and hydroxyl radicals. At pH values less than 6.0, the bicarbonate 
concentration was 32% of total carbonate concentration and the concentration of CO3
2-
 
was negligible. pCBA was added to track hydroxyl radical exposure.  
Carbonate-free water was prepared by bubbling deionized water with nitrogen gas 
to purge CO2 for more than 30 minutes. Then a certain amount of 0.5 M Na2CO3 stock 
solution was added to achieve the required total carbonate concentration; pH was then 
adjusted by adding concentrated NaOH or HCl under a gentle stream of nitrogen to reach 
a final value of 6.0 (Elovitz et al., 2000).  
3.3.6 Buffer experiment (Experiment Set No.5) 
Phosphate buffer experiments were conducted at pH 6 with 0 mM carbonate to 
study the effect of phosphate buffer on ozonation of erythromycin. The concentrations of 
phosphate buffer were 1 mM, 5 mM and 10 mM. Note that even the initial pCBA 
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concentration was not identical for the three experiments, it will be shown that pCBA 
concentrations did not change during the experiment, meaning that different initial pCBA 
concentrations did not present any problem for comparison of the results from these 
experiments 
3.3.7 Initial ozone dose experiment (Experiment Set No.6) 
For this set of experiments, initial ozone dose was the only variable. Experiments 
were conducted at pH 6 with 0 mM carbonate buffer and 5 mM phosphate buffer. Initial 
ozone doses were 0.11, 0.17 and 0.27 mg/L. 
3.4 ANALYTICAL METHODS 
3.4.1 Chemicals and stock solutions 
Erythromycin was purchased from Teknova. t-butanol and para-chlorobenzoic 
acid (pCBA) came from Fisher Scientific and Acros Organics, respectively. Stock 
solutions of erythromycin and pCBA were prepared at 1.36 mM (1 g/L) and 200 μM 
(31.2 mg/L), respectively. Both solutions were stored in the dark at 4°C. Stock solutions 
of phosphate buffer and Na2CO3 were both prepared at 0.5 M.  
3.4.2 Ozone 
The measurement of ozone is described in detail by Marron (2010). Briefly, the 
concentration of ozone stock solution was measured by direct ozone absorbance at 258 
nm based on the known molar absorptivity of ozone while the samples were measured by 
the Indigo colometric method (4500-O3 Residual; AWWA, 2005).  
For measuring stock solutions, 500 μL of stock solution were added to a 1 cm 
quartz cuvette containing 3.5 mL of 5 mM phosphate buffer. The solution was covered 
with a Teflon cap immediately. The sample was analyzed using a spectrophotometer 
(Agilent 8453) within 30 seconds to minimize ozone decomposition. Ozone 










 (Equation 3.1) 





) and path length of the cuvette (1 cm). All experiments were doused with 
a specific concentration of aqueous ozone stock solution based on the measured 
concentration. Specific glass pipettes were used to dose ozone.  
For measuring ozone in reaction solutions, the samples were quenched with 1 mL 
or 2 mL of indigo reagent II. Sample absorbance was analyzed in a 4 cm glass cuvette at 
600 nm. A blank sample with respect to ozone was taken right before the experiment. 










L nm  (Equation 3.2) 
where ΔA600nm is the difference in absorbance at 600 nm between sample and blank; L is 
the path length of cuvette (4 cm).  
As a result of rapid sampling (about 10 s per sample), the mark of the dispenser 
was easily displaced during the experiment; therefore, mass difference before and after 
sampling was used to get the exact sample volume. The concentration calculation based 











/O mg 3  (Equation 3.3) 
where AB and AS are the absorbance of blank and sample, respectively; VS and VT are the 
volume of sample and total volume of sample plus indigo, measured by weight difference 
before and after sampling. b is the path length of the cell and 0.42 is a reasonable for f.  
3.4.3 LC/MS 
Liquid Chromatography/Mass Spectrometry (LC/MS) was employed to detect 
erythromycin. The method was developed based on Calamari et al. (2003) and then 
modified in this research. The separation column used is Premier C18 (150 mm × 
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4.6 mm, 5 μm) with a binary gradient eluent system (solvent A: LC/MS grade methanol; 
solvent B: 0.1% formic acid in water) and a flow rate of 700 μL/min. The eluent gradient 
is shown in Table 3.2. The parent ion mass is 716.4 and the product ion mass is 558.3. 
For the MS settings, the sheath gas pressure was 25 psi; auxiliary pressure was 5 psi; 
collision pressure was 1.5 mTorr; the spray voltage is 4000 V; the vaporizer temperature 
was 400°C. The injection volume was 20 μL and total run time was 18min. The 
calibration curve of erythromycin is shown in Appendix A. 
Table 3.2 Eluent gradient for erythromycin detection by LC/MS 
Time (min) Methanol 0.1% Formic Acid 
0 0% 100% 
3 12% 88% 
10 25% 75% 
12.1 50% 50% 
16.1 50% 50% 
18 88% 12% 
3.4.4 High Performance Liquid Chromatography 
High performance liquid chromatography (HPLC; Water Corporation, Milford, 
MA) was used for pCBA detection. A Sonoma C18 column (3 μm particle size, 3.2 mm 
by 150 mm) was employed; flow rate was 0.7 mL/min and column temperature was 
40°C; sample volume was 10 μL and sample time was 10 min for each sample. Analysis 
of pCBA was based on the method described by (De Witte et al., 2009): a mobile phase 
containing 75% water (0.1% phosphoric acid) and 25% ACN with quantification at 
234 nm. pCBA was detected around 5.3 min. The calibration curve of pCBA is shown in 
Appendix B.  
3.4.5 pH 
pH were measured by a Thermo Electron Corporation pH meter (Orion 720 A+) 
at ambient temperature. The probe was calibrated before use with three standard buffers 
(pH 4.0, 7.0 and 10.0).
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Chapter 4 Results 
The ultimate purpose of this research was to delineate the effects of pH, carbonate 
and phosphate buffers, and initial ozone dose on the kinetics of removal of the antibiotic 
erythromycin by ozonation. Similar research was performed with another antibiotic, 
ciprofloxacin (Marron, 2010), which provided the initial design criteria and preliminary 
results verifying the expected performance of the reactor, including ozone reactor setup 
(see Chapter 3), pCBA detection method (see Chapter 3) and tracer studies (Section 4.2). 
Based on the results obtained from previous research, several sets of experiments were 
conducted to achieve the goals of this research. The first set of experiments was designed 
to determine the second-order rate constant for erythromycin degradation by ozone. 
Three additional sets of experiments examined the effect of carbonate and phosphate 
buffers, and initial ozone dose on erythromycin degradation by ozonation, respectively. 
Two separate sets of experiments were conducted to confirm the effect of carbonate 
buffer on ozone decomposition and its effect on erythromycin degradation by ozone only. 
All experiments were conducted at room temperature in a batch reactor with pH, 
carbonate and phosphate buffers, and/or initial ozone dose as variables.  
4.1 PROBLEM RELATED TO ERYTHROMYCIN STOCK SOLUTION 
An issue related to stock solution was discovered after all the experiments were 
finished. This issue will be described as follows and should be considered when the 
results presented by this thesis are being considered.  
Per the discussion in Section 2.2.3, erythromycin undergoes self-degradation by 
losing one water molecule to form erythromycin-H2O. This self-degradation is also 
expected to occur in the erythromycin stock solution, which resulted in an unstable 
erythromycin stock solution in which the speciation of erythromycin and erythromycin-
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H2O varied with time. Due to this problem with the stock solution, the initial solutions of 
all the experiments were not exactly identical. Fortunately, the rate of self-degradation of 
erythromycin is relatively slow and the experiments are conducted over short time 
periods.  As a result, changes in the concentration of erythromycin in the stock solution 
during the experiments were minimal. 
4.1.1 Self-degradation rate of erythromycin 
The self-degradation of erythromycin can be described by a first-order reaction 
with respect to the concentration of erythromycin. Equation 2.2 described a proposed 
model to interpret the observed degradation rate constant as a function of pH at 25°C. 
However, the stock solution was always kept in 4°C room except during the short time 
periods in which it was removed to perform experiments. Therefore, experimental data 
was employed to determine the self-degradation rate of erythromycin at 4°C.  
Three measurements of the speciation of erythromycin stock solution were carried 
out at day 62, 64 and 69. The speciation between erythromycin and erythromycin-H2O 
was shown in Table 4.1. 
Table 4.1 Speciation data for erythromycin stock solution 
Day Erythromycin (%) Erythromycin-H2O (%) ln([Ery]/[Ery]0) 
0 100 0 0 
62 76.0 24.0 -0.274 
64 76.3 23.7 -0.271 
69 75.5 24.5 -0.281 







ln  (Equation 4.1) 
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By plotting ln[Ery]/[Ery]0 against time, the linear regression slope is the observed 
self-degradation rate constant for erythromycin at 4°C. As shown by Figure 4.1, the self-




Figure 4.1 Verification of first-order model for self-degradation erythromycin at 4°C 
4.1.2 The change of erythromycin stock solution 
Once the self-degradation rate constant was obtained, the change in erythromycin 
concentration in the stock solution was tracked for to estimate the potential impact on the 
experimental results. The relative change in the erythromycin stock solution during a 






























 (Equation 4.2) 
By inserting the observed degradation rate constant and the time periods 
considered relative change in concentration of erythromycin in the stock solution was 
calculated to be 2.89%, 5.71% and 11.8% for time periods of one week, two weeks and 
30 days, respectively. For the six sets of experiments completed in this thesis, each set of 
y = -0.0042x - 0.0012 





















experiments was completed within two weeks; therefore, for each set of the experiments, 
the stock solution remained relatively constant. However, the exact speciation of the 
stock solution was not determined. As a result, the data presented by this thesis is only 
applicable under certain conditions. Nevertheless, as evident from the above discussion, 
the relatively constant stock solution during the experimental period suggests that 
comparisons within each set of experiments valid.  
4.2 SUMMARY OF PREVIOUS EXPERIMENTAL RESULTS   
Tracer studies were performed on the experimental reactor in previous research 
conducted by Marron (2010). The results showed that the reactor did not achieve 
complete mixing until approximately 15 s after the addition of ozone, meaning that there 
would be a potential systematic bias if samples were taken within the first 15 s and this 
bias might be reflected in the estimation of rate constants based on the experimental data. 
Nevertheless, the same research showed that the incomplete mixing during the initial 
period did not significantly impact the values of rate constants determined using data 
collected during this time period .  
As noted in the literature review, data from previous research by Marron (2010) 
and others (Buffle et al. 2006a; Wert et al., 2009) exhibited an instantaneous ozone 
demand. This initial rapid reduction in ozone concentration at the beginning of the 
experiment was also observed in this research. Marron (2010) did not consider the 
instantaneous ozone demand for determination of the kinetics of ciprofloxacin in her 
research, and a similar approach was used for this research. 
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4.3 DETERMINATION OF ERYTHROMYCIN OXIDATION RATE CONSTANT BY OZONE AND 
THE EFFECT OF PH 
The objectives of this set of experiments were to determine the second-order rate 
constant for the reactions of erythromycin and ozone and to quantify the effect of pH on 
the apparent second-order rate constant.3 Tert-butanol (t-butanol) was added to eliminate 
oxidation by hydroxyl radicals. Since the carbonate buffer and natural organic matter 
only affect the ozone decomposition rate, i.e., hydroxyl radical exposure, they were not 
included in this set of experiments. Results from the experiment conducted at pH 6 are 
used here to illustrate the approach for determining the apparent second-order rate 
constant between erythromycin and ozone.  
4.3.1 Analysis of a single experiment (pH 6) 
A single experiment was performed at pH 6 in deionized water with 1 mM 
phosphate buffer, 10 mM t-butanol and negligible carbonate. The reaction was initiated 
by the addition of ozone stock solution at time zero; samples were taken at recorded 
times during the experiment and concentrations of ozone and erythromycin were 
monitored.  
Ozone concentration was determined by the indigo method described in 
Section 3.4.2. Ozone exposure was calculated by numerically integrating the ozone 






















   (Equation 4.3) 
where i and N represent the first and last data point of the experiment, respectively.  
                                                 
3 Note that “apparent second-order rate constant” refers to the observed rate constant under a specific pH while “second-order rate 
constant” without “apparent” refers to the rate constant between ozone and deprotonated erythromycin, which is independent of pH as 
explained in Section 4.3.3 . 
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Figure 4.2 shows the ozone concentration profile and ozone exposure for this 
experiment. Instantaneous ozone demand appeared for the first sample (second data 
point). For the following samples, ozone concentration remained almost unchanged 
(standard deviation less than 7%) for two reasons: first, the decomposition of ozone in 
this experiment was relatively slow because the concentration of hydroxyl anions which 
initiate ozone decomposition was small at pH 6; second, according to the rate constant 
calculated in the following section, ozone reacted very fast with erythromycin so that 
even a small amount of ozone was able to cause significant degradation of erythromycin. 
The small fluctuation of ozone concentration might be due to the sampling and measuring 
error. 
 
Figure 4.2: Ozone concentration and ozone exposure profiles from experiment at pH 6 























































Since t-butanol was added to isolate the reaction between erythromycin and 
ozone, the degradation of erythromycin was only caused by the presence of ozone, which 
can be described as a second-order reaction, first order with respect to ozone and 








tot   (Equation 4.4) 
Ery represents erythromycin and [Ery]tot is the concentration of erythromycin within the 
reactor4; EryappOk ,,3 is the apparent second-order rate constant for erythromycin with ozone. 









 (Equation 4.5) 
where [Ery]0 is the initial concentration of erythromycin that was measured directly. 
Based on Equation 4.5, the apparent second-order rate constant EryappOk ,,3 can be 
obtained using ozone exposure data and erythromycin concentration profiles. By plotting 
the log transformed normalized erythromycin concentration against ozone exposure, the 
linearly regressed slope is the apparent second-order rate constant EryappOk ,,3 for the 
reaction between erythromycin and ozone. Figure 4.3 shows that at pH 6, the apparent 
second-order rate constant was 7.10 103 M-1∙s-1 (R2=0.9969).  
 
                                                 
4 [Ery]tot refers to the total concentration of erythromycin, including deprotonated form and protonated form. In the rest of this thesis, 
[Ery] is used as total erythromycin concentration instead of [Ery]tot if not pointed particularly. 
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Figure 4.3: Illustration of approach to determine the apparent second-order rate constant 
of erythromycin oxidation by ozone (pH 6, 1 mg/L erythromycin, 1 mM phosphate 
buffer, 10 mM t-butanol, negligible carbonate)  
4.3.2 Effect of pH on erythromycin degradation rate constant by ozone 
Five parallel experiments were conducted at five different pH values (pH 5.35, 
5.66, 6.00, 6.40, 6.81) to determine the effect of pH on the apparent second-order rate 
constant for reaction between erythromycin and ozone.  
Experimental results showed that even within the narrow pH range from 5.35 to 
6.81, the apparent second-order rate constants differed substantially, i.e., the slope of the 
ln([Ery]/[Ery]0) vs. ozone exposure differed considerably (see Figure 4.4). As the pH 
increased from 5.35 to 6.81, the apparent second-order rate constant increased by a factor 
of approximately 30. This strong pH dependency of the apparent second-order rate 
constant was also observed in studies on a similar compound, roxithromycin, which also 
y = -7104.8x 


















Ozone Exposure (M-s) 
10mM t-butanol, pH 6   
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belongs to the macrolide antibiotics category and is also characterized by a tertiary amine 
group (Huber et al., 2003; Dodd et al., 2006).  
Erythromycin has a pKa of 8.8; the strong pH dependence of EryappOk ,,3 suggests 
that ozone reacts primarily with the deprotonated amine group while the reaction between 
ozone and the protonated amine group could be neglected (Dodd et al., 2006). Therefore, 
at acidic pH values, when protonated erythromycin predominates, a lower reaction rate is 
expected; on the contrary, at alkaline pHs, when deprotonated erythromycin 
predominates, a higher reaction rate is expected. Moreover, the continuous increase in 
EryappOk ,,3 with increasing pH due to deprotonation of erythromycin’s tertiary amine, 





Figure 4.4 Experimental results of erythromycin oxidation by ozone at different pHs. 
(1 mg/L erythromycin, 1 mM phosphate buffer, 10 mM t-butanol, negligible carbonate) 
Points are experimental data and lines are linear regression results.  
4.3.3 Rate constant for deprotonated erythromycin degradation by ozone 
Since erythromycin only undergoes one proton dissociation within the pH range 
considered, indicated by its unique pKa, a model initially proposed by (Hoigné & Bader 
1983) and later applied by other researchers (Javier Benitez et al., 2003) is employed here 
to obtain the second-order rate constant between deprotonated erythromycin5 and ozone. 
The overall ozonation rate of erythromycin can be expressed as: 
                                                 






























    
  (Equation 4.6) 
where EryOk ,3
is the rate constant between ozone and protonated erythromycin (Ery
+
). 




















  (Equation 4.7) 

































 (Equation 4.9) 
For each data point in Figure 4.3, there would be a data pair of ln([Ery]/[Ery]0) 









slope yields the value of EryOk ,3 , which is shown in Figure 4.5. The second-order rate 







. Huber et al., (2003) reported the second-order rate constant for roxithromycin 
with ozone as (4.5±0.5) 106 M-1∙s-1, which is very close to the value obtained in this 
study. This confirms that for macrolide antibiotics, ozone reacts with the common tertiary 
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amine group. A similar value (4 106 M-1∙s-1) was also reported for reactions between free 
tertiary amine and ozone by (Lange et al., 2006).  
 
 
Figure 4.5: Illustration of approach to determine the second-order rate constant of 
erythromycin oxidation by ozone  
Once EryOk ,3  is known, the apparent second-order rate constant EryappOk ,,3 could be 
back calculated for any pH (See Table 4.2). The experimental data points can also be 
modeled based on the value of EryappOk ,,3  for each pH value. Figure 4.6 shows the results 
of modeling this data using different ordinates. As can be seen from the two figures, the 
model provides a better fit around pH 6; at lower or higher pH, the model does not match 
the data perfectly. At high pH, the reaction between erythromycin and ozone was too 
rapid and there was likely more sampling error; at low pH, the reaction was so slow that 
y = -4.436E+06x 




















ozone depletion caused by processes other than the reaction with the tertiary amine group 
cannot be fully neglected (Lange et al., 2006).  
Table 4.2: Apparent second-order rate constant of erythromycin oxidation by ozone at 
five experiment pH based on EryOk ,3
 and speciation coefficient 
1  





5.35 3.55E-04 1.57E+03 
5.66 9.99E-04 4.43E+03 
6.00 1.58E-03 7.02E+03 
6.40 3.97E-03 1.76E+04 








Figure 4.6: Modeling results of erythromycin oxidation by ozone at different pHs (a) y-
axis being ln([Ery]/[Ery]0); (b) y-axis being [Ery]/[Ery]0. Data are plotted as symbols and 





























































The half-life concept can also be applied to evaluate the performance of 
erythromycin degradation by ozonation. When a constant ozone concentration of 1 mg/L 















  (Equation 4.10) 
Figure 4.7 shows the half-life of erythromycin (for [O3] =1mg/L) and apparent 
second-order rate constant EryappOk ,,3  as a function of pH. By comparing Figure 4.7 and 
Figure 1 from (Huber et al. 2003), the similarity between the data collected for 
erythromycin and roxithromycin is evident. At pH 7, the rate constant for erythromycin 






. Huber et al. (2003) 













Figure 4.7: Half-life and apparent second-order rate constant for erythromycin 
degradation by ozone as a function of pH. (The half-life is calculated for an ozone 
concentration of 1 mg/L; reactions with 
º
OH neglected)   
4.3.4 Effect of carbonate buffer on erythromycin degradation by ozone only 
As pointed out at the beginning of Section 4.3, the effect of carbonate buffer was 
not taken into consideration for this set of pH experiments since carbonate buffer only 
affects ozone decomposition, i.e., the hydroxyl radical exposure. To confirm that 
carbonate had no effect under these conditions, a separate experiment was conducted to 
verify that the rate constant of degradation of erythromycin, or deprotonated 
erythromycin, by ozone was the same regardless of carbonate buffer concentration.  
The experiment was carried out under exactly the same conditions as the pH 6 
experiment, which was used as an illustration in Section 4.3.1, except that a total 


















































the reactor. The same analysis method was used to determine the observed rate constant 
for this experiment. The results from the two experiments are compared in Figure 4.8. 
The data from the two experiments followed the same trend with apparent second-order 
rate constant of 7.10 104 M-1∙s-1 with negligible carbonate6 and 7.56 104 M-1∙s-1 with 
4mM total carbonate. The difference between the two rate constants was only 6.25%, 
which was within the level of experimental error for this research. Therefore, the 
assumption that carbonate buffer would not affect the reactions between erythromycin 
and ozone has been verified.   
 
Figure 4.8: Degradation of erythromycin by ozone only at negligible carbonate and 4 mM 
total carbonate (pH=6, 10 mM t-butanol, 1 mM phosphate buffer)  
                                                 






















4.4 EFFECT OF CARBONATE BUFFER  
The degradation of erythromycin is caused by both ozone and hydroxyl radicals 
that form during ozone decomposition (when t-butanol is not added as a hydroxyl radical 





known to be ozone decomposition inhibitors since they consume hydroxyl radicals and 
do not accelerate the chain reaction as described in Section 2.4.2 (Staehelin & Hoigne 
1985). Therefore, carbonate buffer would theoretically affect the performance of 
erythromycin degradation by ozonation or AOP indirectly since ozone decomposition is 
directly affected by carbonate buffer. Two sets of experiments were conducted to confirm 
the effect of carbonate buffer on ozone decomposition and then to investigate the effect 
of carbonate buffer on erythromycin degradation by ozonation (ozone and hydroxyl 
radicals).  
4.4.1 Effects of carbonate buffer on ozone decomposition 
The goal of the first set of experiments was to confirm the effect of carbonate 
buffer on aqueous ozone decomposition through the quantification of hydroxyl radical 
exposure and by obtaining an Rct value. The total carbonate concentration was the only 
variable in this set of experiments conducted at pH 6; bicarbonate concentration was 32% 
of the total carbonate concentration at this pH and the CO3
2-
 concentration was negligible. 
Erythromycin was not added in this set of experiment; other experimental conditions are 
shown in Table 3.1. 
It is known that initial ozone dose would also affect the ozone decomposition rate 
(Buffle et al., 2006a); therefore, the initial ozone doses for these three experiments were 




Table 4.3: Rct, initial ozone dose, ozone exposure and hydroxyl radical exposure at 1min 




















0 9.91E-07 0.579 5.274 5.226 
0.5 1.75E-07 0.685 6.612 1.160 
1 5.73E-08 0.624 7.170 0.411 
The concentration of hydroxyl radicals cannot be measured directly; therefore, a 
probe compound, para-chlorobenzoic acid (pCBA) was used to quantify hydroxyl radical 
concentration. The reaction of pCBA with hydroxyl radicals follows a second-order rate 
law. The second-order rate constant of 5.2 109 M-1∙s-1 is significantly higher than the a 




that has been reported for ozone; therefore, the 
disappearance of pCBA can be used to track hydroxyl radical concentrations since the 
disappearance of pCBA only occurs through reaction with hydroxyl radicals. The 









  (Equation 4.11) 
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  (Equation 4.12) 
Rct is used to describe ozone decomposition and is defined as the ratio of hydroxyl 













 (Equation 4.13) 





 depending on the background water matrix (Elovitz & von Gunten 1999; 
Elovitz et al., 2000).  









 (Equation 4.14) 
By plotting ln[pCBA]/[pCBA]0 against ozone exposure, Rct is the linear 




. The results are shown in Figure 4.9 with 0 mM, 
0.5 mM and 1 mM total carbonate concentration, respectively. The Rct value decreased 
by almost an order of magnitude as the total carbonate concentration increased from 0 
mM to 1 mM. 
 
Figure 4.9: ln([pCBA]/[pCBA]0) vs. Ozone exposure at 0 mM, 0.5 mM, 1 mM total 
carbonate concentration (pH=6, 1 mM buffer, 1 μM initial pCBA, no erythromycin) 
y = -0.5153x 
y = -0.0912x 




























Once the Rct value was obtained, the hydroxyl radical exposure could be back 
calculated using Equation 4.13. Note that the calculation of ozone exposure and hydroxyl 
radical exposure presented in Table 4.3 and  
Figure 4.10 were based on a one minute experimental time frame. Again, by 
comparing ozone exposure and hydroxyl radical exposure from the three experiments, 
under the same initial ozone concentration (the solid line in  
Figure 4.10) and same time frame (1 min), ozone decomposition was greatly 
inhibited by the presence of carbonate; ozone exposure increased by 36% and hydroxyl 
radical exposure decreased by a factor of approximately 12 when the total carbonate 
concentration increased from 0 mM to 1 mM. The higher ozone exposure and lower 
hydroxyl radical exposure resulted in a small Rct value at high carbonate concentration. 
The decrease in Rct value and hydroxyl radical exposure with increasing carbonate 
concentration demonstrated impact of carbonate buffer as an inhibitor to ozone 
decomposition. These results are as expected and consistent with other research results 







Figure 4.10: Ozone exposure, hydroxyl radical exposure and initial ozone dose at 0 mM, 
0.5 mM and 1 mM total carbonate concentration (Exposures are calculated based on 1min 
with initial ozone dose of 0.58, 0.69, 0.62 mg/L, respectively; pH=6, 1 mM phosphate 
buffer, 1 μM initial pCBA, no erythromycin). 
4.4.2 Effects of carbonate buffer on erythromycin degradation by ozonation 
The purpose of this set of experiments was to investigate the effect of carbonate 
buffer on erythromycin degradation by ozonation when both ozone and hydroxyl radicals 
were present. Total carbonate concentration was the only variable in this set of 
experiments and the initial ozone dose was kept constant (around a 7% difference). At the 
experimental pH (pH=6), the bicarbonate concentration was 32% of the total carbonate 
concentration and the CO3
2-
 concentration was negligible; other experimental conditions 
are shown in Table 3.1. 
As noted in Section 2.4.4, the disappearance of erythromycin can be described by 







































































Total carbonate concentration (mM) 
Ozone Exposure (1E-04)









is the apparent second-
order rate constant between erythromycin and hydroxyl radicals. 
The first term on the left side of Equation 4.15 represents the direct oxidation of 
erythromycin caused by ozone and the second term represents the oxidation caused by 
hydroxyl radicals.  












  (Equation 4.16) 










  (Equation 4.17) 
 ctEryOHEryappOT Rkkk ,,,3   (Equation 4.18) 
kT is the overall rate constant for oxidation of erythromycin caused by both ozone 
and hydroxyl radicals. By plotting ln([Ery]/[Ery]0) against ozone exposure, the overall 
rate constant kT can be determined from the linear regression slope. 
Figure 4.11 shows the results from experiments with 0 mM, 1 mM, 2 mM and 
4 mM total carbonate concentration. Although the total carbonate concentration increased 







; all of the results are considered to be identical. As confirmed 
by Section 4.3.4, the carbonate buffer did not affect the rate constant for the reaction of 
ozone with erythromycin, i.e., the first term of kT— EryappOk ,,3 . Therefore, it is reasonable 
to assume that the second term in the expression for kT, i.e., the hydroxyl radical 
degradation term, imparted either a negligible contribution or remained constant 
regardless of total carbonate concentration. However, Section 4.4.1 did show that the 
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carbonate buffer had a large impact on ozone decomposition as indicated by changes in 
the magnitude of Rct for different total carbonate concentrations. Consequently, it is 
inferred that hydroxyl radicals were not the primary oxidant for degradation of 
erythromycin; hence, even though the carbonate buffer showed a significant impact on 
ozone decomposition itself, it had no appreciable effect on the degradation of 
erythromycin during ozonation. Kim & Tanaka (2010) studied the removal efficiency of 
13 pharmaceuticals including erythromycin and the results showed slightly higher 
removal efficiency with an ozone process compared with the O3/H2O2 process; they 
concluded that ozone was the primary oxidant responsible for degradation of the 13 
pharmaceuticals during O3/H2O2 process. This conclusion coincides with the results of 









Figure 4.11: Effect of carbonate concentration on erythromycin degradation by ozonation 
(a) y-axis being ln([Ery]/[Ery]0); (b) y-axis being [Ery]/[Ery]0.(pH=6, 1 mM phosphate 
































































 at pH 6, see Table 4.2). The slightly 
higher rate constant was expected since, in the absence of t-butanol, hydroxyl radicals 
were not scavenged and participated in the degradation of erythromycin. Even though 
hydroxyl radicals are not the primary oxidant for erythromycin, there was a measurable 
contribution of hydroxyl radicals to the overall removal of erythromycin.   
On the other hand, pCBA added into the reactor at the beginning of the 
experiment for the purpose of tracking hydroxyl radicals did not change within the time 
frame of all of the experiments, suggesting that no significant hydroxyl radical exposure 
was available. As a result, the Rct concept was not appropriate for determining hydroxyl 
radical exposure in this case.  
That pCBA concentration did not change during the experiment could also be 
interpreted based on the relative rates of removal of erythromycin and pCBA. From 





, which was considered a very fast reaction. Based on the 
results from Section 4.4.1 and previous research (Elovitz & von Gunten 1999; Elovitz et 




. Consider an Rct value of 10
-8
 for 





); however, the reaction between pCBA and hydroxyl radicals can be 
transformed into the indirect reaction of pCBA and ozone using the Rct value as shown:: 












  (Equation 4.19)  
where pCBAappOk ,,3 represents the indirect rate constant between ozone and pCBA. 
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Inserting the value of Rct and pCBAOHk ,  at pH 6, the rate constant for the indirect 
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) demonstrates that 
erythromycin reacts much faster than pCBA with ozone. When erythromycin is degraded 
to less than 10%, pCBA remains at 98% of the initial concentration (see Appendix C). In 
other words, before there is a noticable pCBA concentration change, erythromycin is 
already gone, i.e., erythromycin and pCBA change cannot be tracked at the same time. 
Even if an Rct value of 10
-7
 is applied, erythromycin still reacts 10 times faster than 
pCBA. Therefore, it is reasonable that pCBA did not change during the experiments in 
which erythromycin degraded appreciably. This demonstrates a new scenario for which 
the Rct concept is not valid; namely, when degradation of the compound of interest is 
degraded before hydroxyl radical exposure can be determined.  
That pCBA did not change during the experiments and identical overall rate 
constants were obtained from four different experiments confirms that degradation of 
erythromycin is primarily caused by ozone, whereas hydroxyl radicals have a relatively 
minor contribution to the degradation of erythromycin during ozonation. Moreover, 
hydroxyl radicals could not be quantified using pCBA as a probe molecule because the 
reaction between ozone and erythromycin dominated the loss of ozone in the system. 
Although the presence of carbonate buffer does greatly influence ozone decomposition, it 
had a negligible effect on the overall removal of erythromycin by ozonation.  
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4.5 EFFECTS OF PHOSPHATE BUFFER  
Phosphate has been reported to be an efficient ozone decomposition inhibitor at 
typical buffer concentrations (Staehelin & Hoigne 1985; Morozov & Ershov 2010). At all 
pH values, ozone decomposition rate constants decreased as phosphate concentration 
increased (Morozov & Ershov 2010).  
This set of experiments evaluated the effect of phosphate buffer on erythromycin 
degradation by ozonation. Similar to the carbonate buffer experiments, phosphate buffer 
concentration was the only variable; all experiments were conducted with 0 mM total 
carbonate. The initial concentration of ozone was maintained within 10% difference. 
Other experimental conditions are shown in Table 3.1. 
Figure 4.12 shows the results of experiments conducted at 1 mM, 5 mM and 
10 mM phosphate buffer. It can be seen that the three experiments roughly followed the 
same trend, which was similar to the results found in carbonate buffer experiments. The 
overall rate constant kT from the three experiments differed by 9.8% which is thought to 
be caused by the 10% difference in initial ozone dose. Meanwhile, pCBA concentration 
didn’t change in this set of experiments. These two results lead to the conclusion that, 
although phosphate buffer was reported to have an impact on ozone decomposition, it had 
negligible effect on erythromycin degradation by ozonation. 







; this value was again greater than EryappOk ,,3  for the same reason explained in Section 






 was very close to the average overall rate 






); this again indicated 
that ozone was the primary oxidant for erythromycin degradation. 
 61 
 
Figure 4.12: Effect of phosphate buffer on erythromycin degradation by ozonation (a) y-
axis being ln([Ery]/[Ery]0); (b) y-axis being [Ery]/[Ery]0.(pH=6, 0 mM total carbonate, 















































4.6 EFFECTS OF INITIAL OZONE DOSE  
Initial ozone dose is a key control parameter in full-scale ozonation plants and it is 
reported to have a great impact on ozone decomposition (Buffle et al., 2006a). However, 
as demonstrated by Section 4.4 and Section 4.5, ozone was the primary oxidant 
responsible for the degradation of erythromycin. Therefore, it was expected that initial 
ozone dose would have little effect on erythromycin degradation by ozonation, based on 
the conclusions from the carbonate and phosphate buffer experiments as well as the 
“fact” that the reaction between ozone and erythromycin was modeled by a second-order 
reaction, first order with respect to both ozone and erythromycin. This set of experiments 
was designed to verify whether this assumption was valid. Initial ozone dose was the only 
variable and ranged from 0.11 mg/L to 0.27 mg/L. Other conditions were maintained at 
values shown in Table 3.1. 
Figure 4.13 shows the results from the experiments. It is evident from the figure 
that there is a clear positive relationship between initial ozone dose and the overall rate 
constant for erythromycin degradation. As the initial ozone dose increased from 













 (see Figure 4.14). Clearly, this result disagrees with the expectation 
that initial ozone dose would have negligible impact on the degradation rate of 




Figure 4.13: Effect of initial ozone dose on erythromycin degradation by ozonation. (a) y-
axis being ln([Ery]/[Ery]0); (b) y-axis being [Ery]/[Ery]0.(pH=6, 5 mM phosphate buffer, 



















































Figure 4.14: Total rate constant at different initial ozone dose (pH=6, 5 mM phosphate 
buffer, 1 mg/L erythromycin, 0 mM total carbonate)  
On the other hand, the pCBA concentration did not change during the 
experiments, which excluded the possibility that it hydroxyl radicals caused the increase 
in the overall rate constant as initial ozone concentration increased. 
The apparent linear close relationship between initial ozone dose and overall rate 
constant (Figure 4.14) leads to the possibility that the reaction between erythromycin and 
ozone was actually second-order with respect to ozone instead of first-order, which is 












































k represents the new apparent third-order rate constant with second-order 
respect to ozone concentration7. 














 (Equation 4.21) 
Instead of the “ozone exposure” as in the case of first-order reaction to ozone, a 
“second-order ozone exposure”  dtO
2
3][ appears on the right side of the equation. 



















(][  (Equation 4.22)  
By plotting ln([Ery]/[Ery]0) against second-order ozone exposure, 
"
,,3 EryappO
k is the 
slope of linear regression. Figure 4.15 shows the results when second-order ozone 
exposure was applied to the experiments data. 
 
                                                 
7 To differentiate the two rate constants, double prime was used in the expression of the third-order rate constant. 





Figure 4.15: Effect of ozone initial dose on erythromycin degradation when second-order 
ozone exposure applied (a) y-axis being ln([Ery]/[Ery]0); (b) y-axis being [Ery]/[Ery]0.  

















































When second-order ozone exposure was applied, results from the three 
experiments at different initial ozone concentrations were consistent; that is the rate 
constant between erythromycin and second order ozone exposure was constant. The 
apparent third-order rate constants between erythromycin and ozone at 0.11, 0.17, and 










 with a difference of 
less than 10%. This indicates that second-order ozone exposure is a reasonable possibility 
to explain the effect of initial ozone dose on erythromycin degradation—that is the 
reaction between ozone and erythromycin is actually a second-order reaction with respect 
to ozone.  
In order to test the validity of this hypothesis, further experiments are needed. It is 
recommended that several parallel experiments be conducted with the addition of t-
butanol at the same pH (i.e., pH=6) but with different initial ozone doses to determine 
whether the rate constants differ significantly. If the results show that the rate constants 
are similar, then the results support the hypothesis that in the presence of hydroxyl 
radicals, reaction between erythromycin and ozone follow a second-order kinetic model 
with respect to ozone while in the absence of hydroxyl radicals, the reaction between 
erythromycin and ozone is first-order with respect to ozone.   
4.7 SUMMARY 
This research studied the kinetics of degradation of erythromycin by ozonation 
and the impacts of pH, carbonate and phosphate buffers, and initial ozone dose on the 
performance of erythromycin degradation.  
By conducting experiments at varying pH, protonated erythromycin was found to 
be inert to ozone and the second-order rate constant between deprotonated erythromycin 






. Based on this value, the apparent 
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second-order rate constant between erythromycin and ozone at any pH can be estimated 






 at pH 7. Additional experiments verified the assumption 
that carbonate buffer would not affect the degradation of erythromycin by ozone.   
Carbonate and phosphate buffers are reported to be ozone decomposition 
inhibitors. The effect of carbonate buffer on ozone decomposition was also studied using 
the Rct concept and hydroxyl radical exposure. The results verified that the impacts of 
carbonate and phosphate buffers on the overall oxidation of erythromycin by ozonation 
were negligible, as the total rate constant differed by only 10% or less under a variety of 
conditions for these acid/base systems. Moreover, the fact that pCBA concentration did 
not change during the experiment led to the conclusion that ozone was the primary 
oxidant at erythromycin oxidation. 
Initial ozone dose is also reported to affect ozone decomposition rate and the 
results from ozone dose experiments did show a significant impact of ozone dose on the 
removal rate of erythromycin by ozonation. An overall third-order reaction model, with 
second-order with respect to ozone, was proposed to successfully explain the effect of 
ozone dose on erythromycin oxidation by ozonation. This second-order ozone exposure 
also successfully described data from the carbonate and phosphate buffers experiments 
but did not adequately describe the impact of pH. The failure of applying this model to 
the data from the set of experiments conducted at different pH suggests that further 
research is required to evaluate the impact of ozone dose.
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Chapter 5 Conclusion 
5.1 RESTATEMENT OF OBJECTIVES AND APPROACH 
This research was dedicated to investigate the oxidation of erythromycin by 
ozonation and the effects of various natural water parameters as well as initial ozone 
dose—a key operating parameter. One objective of this study was to obtain the rate 
constant for the reaction between erythromycin and ozone, which has not previously been 
reported. pH, carbonate and phosphate buffers, and initial ozone dose were the variables 
examined in this study because of their importance and ubiquitous presence.  
All experiments were conducted in a batch reactor initiated by the addition of a 
certain amount of the aqueous ozone stock solution at time zero to a solution containing 
erythromycin, the selected buffers and pCBA or t-butanol per the experimental matrix. 
For each set of experiments, only one parameter was chosen as the variable while all the 
other parameters were maintained at identical values. Samples were taken at recorded 
times and the concentrations of ozone, erythromycin, and pCBA were measured. Self-
degradation of erythromycin was shown to be an insignificant issue during the course of 
individual experiments; however, self-degradation in the stock solution employed during 
the experiments should be accounted for when the results presented in this thesis are 
being considered.  
The data from the experiments were modeled using a second-order reaction 
model, first order with respect to oxidant (ozone and hydroxyl radicals) and 
erythromycin. The majority of conclusions drawn from these results are derived from 
comparisons among the second-order rate constants obtained by fitting the model to 
individual data sets. 
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5.2 CONCLUSIONS  
Major results and conclusions from this research are outlined as below: 
1. Ozone only reacts with deprotonated erythromycin; the reaction between 
ozone and protonated erythromycin can be neglected.  
2. The apparent rate constant for the reaction between ozone and erythromycin 
increased by a factor of 10 per unit pH increase at pH values well below the 
pKa of erythromycin due to the deprotonation of erythromycin at higher pH. 
3. For the oxidation of erythromycin by ozonation, ozone is the primary oxidant; 
the oxidation caused by hydroxyl radicals is minor. Therefore, there is no need 
to apply advanced oxidation processes to remove erythromycin since ozone 
oxidation itself is very effective.  
4. Although carbonate and phosphate buffers are known to impact ozone 
decomposition, their effects on the overall erythromycin degradation by 
ozonation are negligible.  
5. The application of the Rct concept (the ratio of hydroxyl radical exposure to 
ozone exposure) was limited in this research because Rct could not be 
quantified before erythromycin was completely degraded by ozone. 
6. Initial ozone dose has a positive impact on erythromycin degradation by 
ozonation. The effect was modeled empirically by second-order ozone 
exposure, although the underlying cause of these results is not understood at 
this time.  
5.3 FUTURE WORK 
Recommendations for future work are outlined as below: 
1. Additional experiments should be done to test the proposed hypothesis that 
the reaction between erythromycin and ozone is first-order with respect to 
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ozone in the absence of hydroxyl radicals and is second-order with respect to 
ozone in the presence of hydroxyl radicals. It is recommended to conduct 
several experiments at constant pH in the presence of t-butanol but with varied 
initial ozone doses to determine whether a single rate constant can adequately 
describe the data collected at different ozone doses.   
2. The method employed in this research failed to obtain the value of the rate 
constant between erythromycin and hydroxyl radical because the Rct concept 
was not applicable. Therefore, in order to obtain the rate constant between 
erythromycin and hydroxyl radicals, alternative oxidation processes are 
recommended for generation of hydroxyl radicals, for example, H2O2/UV or 
H2O2 photolysis.  
3. Although ozonation is very effective at removing erythromycin in the original 
form, oxidation by-products were not investigated in this research. Therefore, 
it would be valuable to track the formation of oxidation by-products and 
assess the potential for these intermediates to exhibit anti-microbial activity.  
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Appendix A Calibration Curve of erythromycin-H2O 
As mentioned in Section 2.2.3, erythromycin-H2O was measured instead of 
erythromycin. The total length of detection was 18 min. The peak of erythromycin-H2O 
occurred around 15.5 min and there was some noise afterwards (see Figure A.1). The 
area ratio of noise to response increased as concentration increased.  
 
 
Figure A.1: Illustration of LC/MS response for erythromycin-H2O detection 
Standard solution was prepared under exactly same condition as samples. The 








Table A.1: LC/MS response for erythromycin-H2O standard solution 
Concentration (ppb) Response Noise Noise/Response 
0 17266 1172 6.79% 
0.05 79659 8755 10.99% 
0.1 153520 20303 13.22% 
0.5 668738 106558 15.93% 




Figure A.2: Calibration curve of erythryomycin-H2O by LC/MS  
y = 6.99E-07x 






































Appendix B Calibration Curve of pCBA 
The data for standard pCBA solution is shown in Table B.1 and calibration curve 
is shown in Figure B.1.  
Table B.1: HPLC response for pCBA standard solution 








Figure B.1: Calibration curve of pCBA   
y = 1E-05x 
































Appendix C Comparison of reaction between erythromycin and ozone 
and reaction between pCBA and ozone 





. Meanwhile, it is estimated that pCBA reacts with ozone indirectly at a 
























 (Equation C. 2) 
Figure C.1 and Figure C.2 show the relative reaction of erythromycin and pCBA 
with ozone with no noticeable pCBA change in first case and with noticeable pCBA 
change in second case. 
  
Figure C.1: Relative reaction of erythromycin and pCBA with ozone under no noticeable 





































Figure C.2: Relative reaction of erythromycin and pCBA with ozone under no noticeable 
pCBA change  
From the above two figures, it is clear that if erythromycin concentration is 
tracked till less than 5%, pCBA remains unchanged; if noticeable pCBA change is 
required, erythromycin is gone immediately. In other words, it is impossible to track the 





































Appendix D Second-order ozone exposure 
Second-order ozone exposure  dtO
2
3][ can be calculated in two ways. The first 
way is shown by Equation 4.22: 


















(][  (Equation 4.20) 






















][  (Equation D.1) 
Comparing this two second-order ozone exposure, the first way is always less 













However, this difference is fully negligible since ozone concentration during the 
experiments was very small (less than 10
-5
 M); the difference between two ozone 
concentration is even smaller. Therefore, the second-order ozone exposure calculated by 
two ways is identical (shown by Figure D.1).  
 
Figure D.1: Two ways of calculating second-order ozone exposure (pH=6, 1 mM buffer, 
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